A PHASE II TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) CONCOMITANT WITH RADIOSURGERY FOR THE TREATMENT OF RECURRENT, BEVACIZUMAB-NAIVE GLIOBLASTOMA

被引：0
|
作者：
Harat, Maciej [1 ]
Blok, Maciej [2 ]
Adamczak-Sobczak, Magda [2 ]
Szymanski, Pawel [2 ]
Miechowicz, Iza [3 ]
Malkowski, Bogdan [1 ]
机构：
[1] Nicolaus Copernicus Univ, Coll Med, Bydgoszcz, Poland
[2] Prof Franciszek Lukaszczyk Oncol Ctr, Bydgoszcz, Poland
[3] Poznan Univ Med Sci, Poznan, Poland
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-46
引用
收藏
页码：52 / 53
页数：3
相关论文
共 50 条
  • [21] Tumor Treating Fields (TTFields) Therapy and Lomustine Chemotherapy for the Treatment of Unresectable Progressive Glioblastoma
    Mergen, Ertan
    Landrock, Sonja
    Chizzali, Barbara
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 1056 - 1062
  • [22] A PHASE 2 STUDY OF NIRAPARIB CONCOMITANT WITH TUMOR TREATING FIELDS (TTFIELDS) IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA (HGG)
    Bagley, S. J.
    Mansour, M.
    Pantel, A.
    Schubert, E.
    Dulal, C.
    Nabavizadeh, A.
    Mohan, S.
    Maloney, E.
    Prior, T.
    Angeloni, N.
    Blessing, C.
    Frangos, S.
    Coghlan, L.
    Wileyto, E. P.
    O'Rourke, D.
    Brem, S.
    Desai, A.
    NEURO-ONCOLOGY, 2023, 25
  • [23] PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAIVE RECURRENT GLIOBLASTOMA
    O'Brien, Barbara
    de Groot, John
    Kamiya-Matsuoka, Carlos
    Weathers, Shiao-Pei
    Bacha, Jeffrey
    Brown, Dennis
    Steino, Anne
    Langlands, John
    Schwartz, Richard
    Kanekal, Sarath
    Lopez, Lorena
    Penas-Prado, Marta
    NEURO-ONCOLOGY, 2018, 20 : 17 - 17
  • [24] IDENTIFYING THE GENETIC SIGNATURE OF RESPONSE IN A PHASE II STUDY OF TUMOR TREATING FIELDS IN RECURRENT GLIOBLASTOMA
    Tran, David
    Warren, Sonisha
    Friedman, William
    Ghiaseddin, Ashley
    Murad, Gregory
    Rahman, Maryam
    Roper, Steven
    Allen, Anne
    Greene, Valerie
    Yachnis, Anthony
    NEURO-ONCOLOGY, 2018, 20 : 164 - 164
  • [25] PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma
    Dono, Antonio
    Mitra, Sonali
    Shah, Mauli
    Takayasu, Takeshi
    Zhu, Jay-Jiguang
    Tandon, Nitin
    Patel, Chirag B.
    Esquenazi, Yoshua
    Ballester, Leomar Y.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (01) : 153 - 160
  • [26] Concomitant application of temozolomide, Tumor Treating Fields (TTFields), and lomustine in glioblastoma cells in vitro indicates better efficacy
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Haber, A.
    Ehrle, S.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S79 - S79
  • [27] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
    Kebir, S.
    Lazaridis, L.
    Schmidt, T.
    Oster, C.
    Pierscianek, D.
    Guberina, N.
    Kleinschnitz, C.
    Proescholdt, M.
    Hau, P.
    Grosu, A. -L
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
  • [28] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2021, 23 : 68 - 68
  • [29] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, S.
    Pierscianek, D.
    Proescholdt, M.
    Hau, P.
    Grosu, A.
    Krex, D.
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    NEURO-ONCOLOGY, 2021, 23 : 50 - 50
  • [30] PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma
    Antonio Dono
    Sonali Mitra
    Mauli Shah
    Takeshi Takayasu
    Jay-Jiguang Zhu
    Nitin Tandon
    Chirag B. Patel
    Yoshua Esquenazi
    Leomar Y. Ballester
    Journal of Neuro-Oncology, 2021, 153 : 153 - 160
12345